Brian Bachmann
-
Quantum Potential Episode 3: Brian Bachmann, professor of chemistry, charts path to personalized treatment
In the third episode of the Quantum Potential podcast, Provost C. Cybele Raver welcomes chemist Brian Bachmann, who is the principal investigator for the Vanderbilt Laboratory for Biosynthetic Studies. Read MoreMarch 3, 2025
-
When curiosity meets leadership: Cybele Raver’s ‘Quantum Potential’ podcast explores solutions for humanity’s greatest challenges
Cybele Raver’s ‘Quantum Potential’ podcast explores solutions for humanity’s greatest challenges. Read MoreJanuary 15, 2025
-
Vanderbilt’s Life Science Showcase focuses on cutting-edge infectious disease research
Infectious diseases pose a significant global health challenge, accounting for a substantial proportion of deaths worldwide, according to recent data from the World Health Organization. Vanderbilt’s Life Science Showcase: Advancing Innovation in Infectious Diseases held on July 18 emphasized the vital importance of advancing research and innovation to combat these persistent threats. Read MoreJuly 23, 2024
-
New screening method could pave the way for future cancer drug discoveries
The laboratories of Brian Bachmann and Jonathan Irish have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. Read MoreJanuary 17, 2023
-
Looking beyond the ‘magic bullet’ approach to drug discovery
Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature. Read MoreMay 1, 2018
-
Bridging the antibiotic gap
Vanderbilt researchers have discovered how certain molecules with antibiotic properties are synthesized, findings that could lead to new drugs that overcome the increased antibiotic resistance in bacteria. Read MoreAugust 7, 2015
-
Shifting evolution into reverse promises cheaper, greener way to make new drugs
By shifting evolution into reverse to produce an expensive HIV drug out of a simple sugar, Vanderbilt chemist Brian Bachmann has shown that it may be possible to manufacture exotic and expensive synthetic drugs as easily as brewing beer. Read MoreMarch 24, 2014
-
Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells
Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years. Read MoreMarch 3, 2014
-
Caving for Cures project gains museum limelight
If you drop by the American Museum of Natural History the next time you visit New York, there is a good chance that you will see an exhibit highlighting Vanderbilt chemist Brian Bachmann’s "caving for drugs" research. Read MoreSeptember 17, 2012
-
Nashville innovations
Last week when the Nashville Scene’s annual Innovations Issue hit the newsstands, three of its ten “forward-thinking ideas that are pushing Nashville – and the world – into the future” came from Vanderbilt. The three campus projects that impressed the Scene editors were: Digging for Drugs:… Read MoreAugust 23, 2011